Adjuvant therapy following surgery in non-small cell lung cancer (NSCLC)

@article{Tanaka2015AdjuvantTF,
  title={Adjuvant therapy following surgery in non-small cell lung cancer (NSCLC)},
  author={Fumihiro Tanaka and Kazue Yoneda},
  journal={Surgery Today},
  year={2015},
  volume={46},
  pages={25-37}
}
Non-small cell lung cancer (NSCLC) accounts for 80–90 % of cases of primary lung cancer. Although surgery is recommended as the primary treatment for early-stage NSCLC, the prognosis is unsatisfactory even when complete resection is achieved. Recent clinical trials have shown that postoperative adjuvant chemotherapy with cytotoxic agents, namely uracil-tegafur (UFT) for stage IA (>2 cm in diameter)-IB patients or cisplatin-based regimens for stage II-IIIA patients, improves the prognosis, and… CONTINUE READING
Highly Cited
This paper has 137 citations. REVIEW CITATIONS

Citations

Publications citing this paper.

138 Citations

050100150201620172018
Citations per Year
Semantic Scholar estimates that this publication has 138 citations based on the available data.

See our FAQ for additional information.

References

Publications referenced by this paper.
Showing 1-10 of 88 references

Committee for Scientific Affairs, The Japanese Association

  • Surgery Thoracic, M Masuda, +4 authors S Endo
  • Gen Thorac Cardiovasc Surg
  • 2014
Highly Influential
14 Excerpts

RADIANT results

  • K Kelly, NK Altorki, +5 authors versus placebo following complete tumor resection with or cancer
  • J Clin Oncol. 2014;32(May 20 supplement):477 s…
  • 2016
1 Excerpt

Similar Papers

Loading similar papers…